Serologic biomarkers for inflammatory bowel disease (IBD) have yielded variable
differentiating ability. Quantitative analysis of a large number of metabolites is a promising …

Background and aims: Inflammatory bowel disease, a chronic inflammation of the intestinal
tract, presents in two variations, Ulcerative Colitis (UC) and Crohn's disease (CD). Given that …

Background The inflammatory bowel diseases (IBD), Crohn's disease (CD), and ulcerative
colitis (UC), are chronic inflammatory conditions of the gastrointestinal tract whose …

Quantitative profiling of a large number of metabolic compounds is a promising method to
detect biomarkers in inflammatory bowel diseases (IBD), such as ulcerative colitis (UC). We …

OBJECTIVES: Distinguishing between the inflammatory bowel disease (IBD), Crohn's
disease (CD), and ulcerative colitis (UC) is important for both management and prognostic …

Abstract Background and Aims Endoscopic assessment of ulcerative colitis [UC] is one of
the most accurate measures of disease activity, but frequent endoscopic investigations are …

AIM: To evaluate the utility of serum and urine metabolomic analysis in diagnosing and
monitoring of inflammatory bowel diseases (IBD). METHODS: Serum and urine samples …

1H NMR spectroscopy of aqueous fecal extracts has been used to investigate differences in
metabolic activity of gut microbiota in patients with ulcerative colitis (UC)(n= 13), irritable …

Inflammatory bowel diseases (IBD) including Crohn's disease (CD) and ulcerative colitis
(UC) have a major impact on the health of individuals and populations. Accurate diagnosis …

Introduction Biomarkers are needed in inflammatory bowel disease (IBD) to help define
disease activity and identify underlying pathogenic mechanisms. We hypothesized that …